CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
Author:
Funder
Bloodwise
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference49 articles.
1. Mechanisms of immune evasion and immune modulation by lymphoma cells;Menter;Front Oncol.,2018
2. Checkpoint inhibitors in hematological malignancies;Ok;J Hematol Oncol.,2017
3. Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lydemphoma to FOXP1;Dekker;Proc Natl Acad Sci USA.,2016
4. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity;Sehn;Blood.,2015
5. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review;Camicia;Mol Cancer.,2015
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment;Nanotechnology;2024-07-17
2. Tree-Structured Parzen Estimator and Ensemble Machine Learning to Predict Early-Stage Pancreatic Cancer;2024
3. CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia;Annals of Hematology;2023-09-22
4. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape;Journal of Translational Medicine;2022-08-19
5. Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?;Biomedicine & Pharmacotherapy;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3